about
Identification of a novel gene family that includes the interferon-inducible human genes 6-16 and ISG12Type I interferon: friend or foe?Passive broad-spectrum influenza immunoprophylaxisL-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirin.Assessment of Cancer-related Fatigue among Cancer Patients Receiving Various Therapies: A Cross-sectional Observational StudyCancer-Related Fatigue, Version 2.2015.Microarray analysis on germfree mice elucidates the primary target of a traditional Japanese medicine juzentaihoto: acceleration of IFN-α response via affecting the ISGF3-IRF7 signaling cascadeCharacterizing fatigue associated with sunitinib and its impact on health-related quality of life in patients with metastatic renal cell carcinomaRelationship between cytokine gene single nucleotide polymorphisms and symptom burden and quality of life in lung cancer survivorsPrevalence, severity, and predictors of fatigue in subjects with primary Sjögren's syndrome.Fatigue in renal cell carcinoma: the hidden burden of current targeted therapiesAntiviral activity of limitin against encephalomyocarditis virus, herpes simplex virus, and mouse hepatitis virus: diverse requirements by limitin and alpha interferon for interferon regulatory factor 1.A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjögren's Syndrome.Brain metabolomic profiles of lung cancer patients prior to treatment characterized by proton magnetic resonance spectroscopyGenetic predictors of fatigue in prostate cancer patients treated with androgen deprivation therapy: preliminary findings.Peripheral Blood Cells from Patients with Autoimmune Addison's Disease Poorly Respond to Interferons In Vitro, Despite Elevated Serum Levels of Interferon-Inducible Chemokines.Management of cancer-related fatigue.Prevalence of fatigue among cancer patients receiving various anticancer therapies and its impact on quality of life: a cross-sectional study.Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression.Using a conceptual model in nursing research--mitigating fatigue in cancer patients.A high level of fatigue among long-term survivors of non-Hodgkin's lymphoma: results from the longitudinal population-based PROFILES registry in the south of the Netherlands.Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokinesEffect of Processed Honey and Royal Jelly on Cancer-Related Fatigue: A Double-Blind Randomized Clinical TrialFatigue and sleep during cancer and chemotherapy: translational rodent modelsLong-term pegylated interferon-alpha and its potential in the treatment of melanomaCancer-related fatigue: a practical review.Side effects in melanoma patients receiving adjuvant interferon alfa-2b therapy: a nurse's perspective.Type I IFN signature in primary Sjögren's syndrome patients.Adverse Events in Cancer Immunotherapy.Fatigue among patients with renal cell carcinoma receiving adjuvant sunitinib or sorafenib: patient-reported outcomes of ECOG-ACRIN E2805 trial.Self-efficacy for coping with cancer in melanoma patients: its association with physical fatigue and depression.Could Objective Tests Be Used to Measure Fatigue in Patients With Advanced Cancer?
P2860
Q21266614-85701863-AF68-408B-A5BA-A19D85A9A69FQ28293186-E3F2AA05-1652-449D-8797-C51A8FF8EEC9Q30367936-1ABE1B4B-1F15-4D88-AC01-35D091BE86E9Q33398403-91827906-9498-4E50-9772-9ECF7199B16CQ33623798-C63037F3-C926-4C19-8778-2A07A5D7757BQ33878583-2B4F5969-8773-4825-8312-2E0CBF80A22AQ34132514-7DF30D61-7044-4E7B-AEF6-83165E306F34Q34507381-A16A2CF9-8E95-4B0C-B283-BB50E38DAC0EQ34878309-8E24E892-4FFF-4809-A628-5D2DA111FFB9Q35020947-D1AC9217-E691-4A1A-AD8A-54A060FD0C88Q35583812-2A4C7173-7676-4388-B9E4-B59DCBC51FC4Q35802799-B463FAA6-8F29-49B2-AC9E-DBC6755351CFQ35875673-4D1FBE40-2CC6-4712-831F-1D5DB8D417F6Q35929573-27F2D303-63BF-41F5-9D93-3AEECC061913Q36101133-B36713FE-1B1A-417F-812B-BCD39910AE77Q36108080-BF6043AA-A3D0-41A9-99E6-1F5F20648B3DQ36156911-F91B43B1-8BF6-4394-88AC-66732382D4C9Q36612753-0ECD65AA-D77C-4A98-8EE1-4C42975F92A1Q36745815-6DFD34A3-5184-4F5C-8E3F-77F437792855Q36825821-FA775325-3ECD-4C78-939B-2729DA6F3C6FQ36862345-57A4FA59-6E14-4839-96B2-8C3FD14981E6Q37133826-342670D5-045E-43DD-986E-85C387B1BF51Q37136082-70B523AC-CD7E-4C4E-AB47-3EE842227EC7Q37203219-462812A9-F45E-4371-824D-6763BF0167C3Q37586916-F3538FB9-0BCA-4D06-894D-4F815506AD0DQ37843136-16D1101D-DC77-4987-82A0-B4213B081DF8Q38007892-5CE99EDA-4FB0-4D51-8872-DE16741C51BEQ38180717-F26BAFE8-ABAD-4935-B0B7-C803F23B8453Q46884498-F5CAA53D-F48B-4372-A464-46900EEF5A49Q47570348-C7B73D67-88B9-4EF1-B487-C829856BD01FQ48323895-665BAF08-3F11-4571-815E-B4F9C08D83A8Q54404415-296D977E-E024-4079-B871-215004FFA4FD
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Interferon-mediated fatigue.
@ast
Interferon-mediated fatigue.
@en
Interferon-mediated fatigue.
@nl
type
label
Interferon-mediated fatigue.
@ast
Interferon-mediated fatigue.
@en
Interferon-mediated fatigue.
@nl
prefLabel
Interferon-mediated fatigue.
@ast
Interferon-mediated fatigue.
@en
Interferon-mediated fatigue.
@nl
P2093
P2860
P1433
P1476
Interferon-mediated fatigue.
@en
P2093
P2860
P304
P356
10.1002/1097-0142(20010915)92:6+<1664::AID-CNCR1494>3.0.CO;2-9
P407
P433
P577
2001-09-01T00:00:00Z